Insider · CIK 0001724311
Alexander O. Schuth
Files at DNLI (Denali Therapeutics Inc.). First filing Nov 12, 2024, latest Sep 3, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
DNLI: Denali Therapeutics Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 18Weak | Denali Therapeutics Inc. | $65k 2,768 shares | -1% | - | |
| 44Moderate | Denali Therapeutics Inc. | $308k 15,162 shares | -6% | - | |
| 12Weak | Denali Therapeutics Inc. | $465k 15,558 shares | -8% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | DNLI Denali Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -2,768 | $23.44 | $65k | 278,995 | 39 d ago |
| Jan 6, 2025 | DNLI Denali Therapeutics Inc. | SOpen-market sale Common Stock | -12,255 | $20.22 | $248k | 247,215 | Jan 8, 2025 |
| Jan 7, 2025 | DNLI Denali Therapeutics Inc. | SOpen-market sale Common Stock | -2,907 | $20.81 | $60k | 244,308 | Jan 8, 2025 |
| Jan 3, 2025 | DNLI Denali Therapeutics Inc. | AGrant or award Common Stock | +54,180 | $0.00 | $0 | 259,470 | Jan 7, 2025 |
| Jan 3, 2025 | DNLI Denali Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +162,540 | $0.00 | $0 | 162,540 | Jan 7, 2025 |
| Dec 27, 2024 | DNLI Denali Therapeutics Inc. | MOption exercise Common Stock | +6,708 | $5.28 | $35k | 205,290 | Dec 31, 2024 |
| Dec 27, 2024 | DNLI Denali Therapeutics Inc. | MOption exercise Stock Option (right to buy)derivative | -6,708 | $0.00 | $0 | 46,671 | Dec 31, 2024 |
| Nov 22, 2024 | DNLI Denali Therapeutics Inc. | MOption exercise Common Stock | +20,516 | $0.68 | $14k | 198,582 | Nov 26, 2024 |
| Nov 22, 2024 | DNLI Denali Therapeutics Inc. | MOption exercise Stock Option (right to buy)derivative | -20,516 | $0.00 | $0 | 124,562 | Nov 26, 2024 |
| Nov 7, 2024 | DNLI Denali Therapeutics Inc. | MOption exercise Common Stock10b5-1 | +15,558 | $5.28 | $82k | 193,624 | Nov 12, 2024 |
| Nov 7, 2024 | DNLI Denali Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -12,333 | $29.68 | $366k | 181,291 | Nov 12, 2024 |
| Nov 7, 2024 | DNLI Denali Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -2,925 | $30.72 | $90k | 178,366 | Nov 12, 2024 |
| Nov 7, 2024 | DNLI Denali Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -300 | $31.29 | $9,387 | 178,066 | Nov 12, 2024 |
| Nov 7, 2024 | DNLI Denali Therapeutics Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -15,558 | $0.00 | $0 | 53,379 | Nov 12, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.